NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Sentiment, Your timeline is based on the MHRA’s official guidance:
- given where we are today
- procedurally it makes sense
- so a latest Nov 2, 2025 approval date also makes sense.

I'm looking at it differently but timing is in the same ballpark:
- I am thinking the gatekeeper is a review at the October 13-16 CHM meeting, then approval is 1 week later, late-October
- (slight chance, if reviewed at Sep 15-18 CHM meeting, then could be at the end of this month).

I am putting a high weight on these critical events:
- the new UK SI 2025 No. 87 on July 23, 2025
(speculation: NWBO amended MAA to include Flaskworks/Eden validation data)

- the acquisition of Advent BioServices on Aug 27, 2025
(interpretation: NWBO received internal signals for upcoming approval of Eden, ie start preparing for commercialization)